Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Induction in Nulliparous Women at 39 Weeks to Prevent Adverse Outcomes: A Randomized Controlled Trial
This study is comparing the outcomes of labor induction versus natural delivery for women with the first pregnancy.
Enrolling:Male and Female Patients
IRB Number:AAAM6619
U.S. Government ID:NCT01990612
Contact: Sabine Bousleiman RN MsPH CCRP: (212) 305-4348 /
Additional Study Information:

The goal of the study is to determine whether coming to the hospital and having the labor started with medicine (i.e., labor induction) at 39 weeks of pregnancy can improve the baby's health at birth when compared with waiting for labor to start on its own.

This study is closed
Cynthia Gyamfi Bannerman, MD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Sabine Bousleiman RN MsPH CCRP
Phone: (212) 305-4348